Sakaeda T, Hirano K
Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.
J Drug Target. 1998;6(4):273-84. doi: 10.3109/10611869808996835.
Plasma concentrations of oil particles after intravenous injection of oil-in-water (O/W) lipid emulsions were monitored based on the plasma concentration of phospholipids (PL) and triglycerides (TG), and the light scattering intensity (LSI) of plasma. Previously, we found that their time profiles after injection of the standard O/W lipid emulsion composed of soybean oil (SO) and egg yolk phosphatides (EYP) were similar and suggested that the oil particles with diameter of about 200 nm were entrapped by reticuloendothelial system (RES). Herein, in order to develop a delivery system to avoid the RES uptake by using the lipid emulsions, biological fate of lipid emulsions with oil particles of various sizes or those emulsified by surfactants with polyoxyethylene segments were subjected to the investigations. Lipid emulsions with oil particles of various sizes (about 150-550 nm) were prepared by altering EYP content. The oil particles were stable in plasma in vitro, but oil particle size decreased time-dependently after intravenous injection. Plasma clearance of oil particles depended on their initial size and was decreased by pretreatment with dextran sulfate 500 (DS500), a known RES suppressor. These results suggested that oil particles are still entrapped by RES, even for small-sized oil particles (about 150 nm). Lipid emulsion with small-sized oil particles was also prepared using medium chain triglycerides. The oil particles were stable in vitro, but the time profiles of plasma concentrations of PL and TG, and LSI of plasma were different, and oil particle size decreased time-dependently after intravenous injection. Plasma clearance of the oil particles also depended on their initial size and was decreased by DS500, suggesting that in vivo instability could be due to RES-mediated processes. Artificial surfactants with polyoxyethylene segments, HCO-60 (HCO60) and polysorbate 80 (PS80), were used for RES avoidance. HCO60 resulted in drastic reduction of the plasma clearance of the oil particles for both lipid emulsions composed of soybean oil and medium chain triglycerides. The time-dependent decrease of oil particle size after intravenous injection was marginal. In contrast, PS80 could not prolong the circulation time of the oil particles, and their size decreased time-dependently after intravenous injection.
基于血浆中磷脂(PL)和甘油三酯(TG)的浓度以及血浆的光散射强度(LSI),对静脉注射水包油(O/W)脂质乳剂后油颗粒的血浆浓度进行了监测。此前,我们发现注射由大豆油(SO)和蛋黄磷脂(EYP)组成的标准O/W脂质乳剂后它们的时间曲线相似,并表明直径约200nm的油颗粒被网状内皮系统(RES)捕获。在此,为了开发一种使用脂质乳剂避免RES摄取的递送系统,对具有各种尺寸油颗粒的脂质乳剂或由具有聚氧乙烯链段的表面活性剂乳化的脂质乳剂的生物学命运进行了研究。通过改变EYP含量制备了具有各种尺寸(约150 - 550nm)油颗粒的脂质乳剂。油颗粒在体外血浆中稳定,但静脉注射后油颗粒大小随时间降低。油颗粒的血浆清除率取决于其初始大小,并且通过用已知的RES抑制剂硫酸葡聚糖500(DS500)预处理而降低。这些结果表明,即使对于小尺寸的油颗粒(约150nm),油颗粒仍被RES捕获。还使用中链甘油三酯制备了具有小尺寸油颗粒的脂质乳剂。油颗粒在体外稳定,但血浆中PL和TG的浓度以及血浆LSI的时间曲线不同,并且静脉注射后油颗粒大小随时间降低。油颗粒的血浆清除率也取决于其初始大小,并被DS500降低,表明体内不稳定性可能是由于RES介导的过程。具有聚氧乙烯链段的人工表面活性剂HCO - 60(HCO60)和聚山梨酯80(PS80)用于避免RES摄取。HCO60导致由大豆油和中链甘油三酯组成的两种脂质乳剂的油颗粒血浆清除率大幅降低。静脉注射后油颗粒大小随时间降低不明显。相比之下,PS80不能延长油颗粒的循环时间,并且它们的大小在静脉注射后随时间降低。